Dialyzer membrane permeability and survival in hemodialysis patients
- PMID: 15754279
- DOI: 10.1053/j.ajkd.2004.11.014
Dialyzer membrane permeability and survival in hemodialysis patients
Abstract
Background: We previously showed that nutritional protein concentrations were predictive of outcome, whereas variables reflecting body composition and dialysis dose were not, in a 30-month prospective follow-up of 1,610 hemodialysis patients. Information on dialysis membrane and erythropoietin use had to be evaluated in an additional follow-up.
Methods: A subset of 650 patients from the initial cohort of 1,610 was analyzed for survival in a 2-year extension of follow-up. Detailed data were collected: demographics; cause of renal failure; time on dialysis therapy; type of membrane; erythropoietin treatment; body mass index (BMI); predialysis albumin, prealbumin, and bicarbonate levels; and outcome. Normalized protein catabolic rate (nPCR), dialysis adequacy, and lean body mass were computed from predialysis and postdialysis urea and creatinine values.
Results: Patient characteristics were age of 61 +/- 16 years, 58% men, BMI of 22.7 +/- 4.4 kg/m2 , time on dialysis therapy of 102 +/- 73 months, and 8.8% had diabetes. Dialysis parameters were duration of 247 +/- 31 minutes, Kt/V of 1.4 +/- 0.3, and nPCR of 1.2 +/- 0.3 g/kg/d. Albumin level was 3.73 +/- 0.53 g/dL (37.3 +/- 5.3 g/L), and prealbumin level was 31 +/- 8 mg/dL. The survival rate was 78.7% after 2 years. Survival was influenced by age, presence of diabetes, use of high-flux membrane, and serum albumin level, but not other variables, including Kt/V and prealbumin level. Two-year variations in values for urea, creatinine, and weight were predictive of survival in univariate, but not multivariate, analyses.
Conclusion: In patients on dialysis therapy for a long period, better survival was observed when high-flux dialysis membranes were used.
Similar articles
-
Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.Nephron Clin Pract. 2008;109(2):c100-8. doi: 10.1159/000142528. Epub 2008 Jul 3. Nephron Clin Pract. 2008. PMID: 18596379
-
[Predictors of early death during dialysis].Nefrologia. 2001 May-Jun;21(3):274-82. Nefrologia. 2001. PMID: 11471308 Spanish.
-
Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.Nephrol Dial Transplant. 2009 Aug;24(8):2536-40. doi: 10.1093/ndt/gfp110. Epub 2009 Mar 17. Nephrol Dial Transplant. 2009. PMID: 19297358 Clinical Trial.
-
Comparison of long-term survival between hemodialysis and peritoneal dialysis.Adv Perit Dial. 1996;12:79-88. Adv Perit Dial. 1996. PMID: 8865878 Review.
-
Association between dialysis dose improvement and nutritional status among hemodialysis patients.Am J Nephrol. 2007;27(2):113-9. doi: 10.1159/000099836. Epub 2007 Feb 15. Am J Nephrol. 2007. PMID: 17308372 Review.
Cited by
-
The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.PLoS One. 2013 Apr 30;8(4):e62239. doi: 10.1371/journal.pone.0062239. Print 2013. PLoS One. 2013. PMID: 23646121 Free PMC article.
-
Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function.PLoS One. 2014 Jun 6;9(6):e97184. doi: 10.1371/journal.pone.0097184. eCollection 2014. PLoS One. 2014. PMID: 24906205 Free PMC article.
-
Performance of hemodialysis with novel medium cut-off dialyzers.Nephrol Dial Transplant. 2017 Jan 1;32(1):165-172. doi: 10.1093/ndt/gfw310. Nephrol Dial Transplant. 2017. PMID: 27587605 Free PMC article. Clinical Trial.
-
Home haemodialysis and uraemic toxin removal: does a happy marriage exist?Nat Rev Nephrol. 2012 Oct;8(10):579-88. doi: 10.1038/nrneph.2012.189. Epub 2012 Aug 28. Nat Rev Nephrol. 2012. PMID: 22926247 Review.
-
The Relationship of Residual Renal Function with Cardiovascular Morbidity in Hemodialysis Patients and the Potential Role of Monocyte Chemoattractant Protein-1.Kidney Dis (Basel). 2018 Feb;4(1):20-28. doi: 10.1159/000484603. Epub 2017 Nov 17. Kidney Dis (Basel). 2018. PMID: 29594139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials